Photodynamic, Photothermal and Photoimmune Therapy and Other Antimicrobial Nanomedicine-Related Applications
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 5611
Special Issue Editors
Interests: nanomedicine; PDT; PTT; PIT; photobiomodulation; nanorobots
Interests: photomedicine; photobiomodulation; photodynamic therapy; new photosensitizers; antimicrobial photodynamic inactivation; nanomedicine; drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: photobiomodulation; radiation therapy; supportive care in cancer; head and neck cancer
Special Issue Information
Dear Colleagues,
This Special Issue welcomes the submission of original research manuscripts or reviews in the area of pharmaceutical sciences and the latest combined integrative therapies such as photothermal, photodynamic and photo-immunotherapy (PTT, PDT, and PIT) and other antimicrobial nanomedicine-related applications, together with light-triggered multifunctional nanoplatforms loaded with novel nanodrugs as smart solutions in synergistic nanomedicine of the future. We invite all of you to contribute interesting papers and cutting-edge results in this exciting research and medical field, and open up additional avenues to accelerate the advancement of innovative approaches for multi-target tumor management, so as to meet the critical needs of patients and redefine cancer therapy. We aim to collect and introspect high-tech medical applications in molecular and cellular research of photosensitizers, new light and laser energy delivery systems, and nanorobots and nanomedicines, as well as the features of photomedicine integration of PTT, PDT, and PIT as molecular-targeted therapies in immuno-oncology, from bench to bedside, as well as other antimicrobial nanomedicine-related applications.
The incredible nanomedical breakthroughs revealed in this Special Issue are expected to bring cancer patients new hope for a longer life expectancy or even a cure. It presents remarkable innovations that can overcome major challenges in cancer therapy, as well as other antimicrobial nanomedicine-related applications.
We plan to receive submissions until 31 July 2024. Manuscripts will be published online on an ongoing basis after being processed.
Dr. Laura Marinela Ailioaie
Prof. Dr. Michael R. Hamblin
Prof. Dr. René-Jean Bensadoun
Dr. Constantin Ailioaie
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial
- cancer therapy
- tumor recurrence and metastasis
- photomedicine
- photobiomodulation
- new photosensitizers
- nanotechnology
- nanomedicine
- photothermal therapy
- photodynamic therapy
- photo-immunotherapy
- clinical applications of PTT, PDT, and PIT
- immunogenic cell death
- drug design
- drug delivery systems
- light-triggered multifunctional nanoplatforms
- controlled release
- unmet clinical needs
- nanotherapies targeting mitochondria
- nanoparticles
- nanosystems
- nanorobots
- nanocarriers
- radiation therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.